CSL Limited
Global biotech leader in plasma-derived therapies and vaccines
Company Overview
Peer Companies
Signal Activity
Signal Timeline
3 totalCSL Seqirus Signs Long-Term Agreement with The Pan-American Health Organization (PAHO) to Advance Regional Influenza Protection in the Region of the Americas
CSL Seqirus entered into a long-term agreement with the Pan-American Health Organization (PAHO) to enhance influenza protection across the Americas.
Lilly and CSL Partner on Clazakizumab Antibody Development
CSL and Eli Lilly have entered into a strategic licensing agreement for the development of clazakizumab, an anti-interleukin-6 (IL-6) monoclonal antibody.
CSL announces expansion of Illinois plasma therapy manufacturing facility
CSL announced a $1.5 billion investment to expand its plasma therapy manufacturing facility in Kankakee, Illinois, which is expected to create at least 300 new jobs.
Get notified when new signals are published for this company.